Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Myelodysplastic Syndrome (MDS) Drugs Market Size Growth Rate by Type (2014-2025) 1.4.2 Hypomethylating Agents 1.4.3 Immunomodulatory Drugs 1.4.4 Anti-anemics 1.5 Market by Application 1.5.1 Global Myelodysplastic Syndrome (MDS) Drugs Market Share by Application (2014-2025) 1.5.2 Original 1.5.3 Generics 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Myelodysplastic Syndrome (MDS) Drugs Market Size 2.2 Myelodysplastic Syndrome (MDS) Drugs Growth Trends by Regions 2.2.1 Myelodysplastic Syndrome (MDS) Drugs Market Size by Regions (2014-2025) 2.2.2 Myelodysplastic Syndrome (MDS) Drugs Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Myelodysplastic Syndrome (MDS) Drugs Market Size by Manufacturers 3.1.1 Global Myelodysplastic Syndrome (MDS) Drugs Revenue by Manufacturers (2014-2019) 3.1.2 Global Myelodysplastic Syndrome (MDS) Drugs Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Myelodysplastic Syndrome (MDS) Drugs Market Concentration Ratio (CR5 and HHI) 3.2 Myelodysplastic Syndrome (MDS) Drugs Key Players Head office and Area Served 3.3 Key Players Myelodysplastic Syndrome (MDS) Drugs Product/Solution/Service 3.4 Date of Enter into Myelodysplastic Syndrome (MDS) Drugs Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Type (2014-2019) 4.2 Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Application (2014-2019) 5 United States 5.1 United States Myelodysplastic Syndrome (MDS) Drugs Market Size (2014-2019) 5.2 Myelodysplastic Syndrome (MDS) Drugs Key Players in United States 5.3 United States Myelodysplastic Syndrome (MDS) Drugs Market Size by Type 5.4 United States Myelodysplastic Syndrome (MDS) Drugs Market Size by Application 6 Europe 6.1 Europe Myelodysplastic Syndrome (MDS) Drugs Market Size (2014-2019) 6.2 Myelodysplastic Syndrome (MDS) Drugs Key Players in Europe 6.3 Europe Myelodysplastic Syndrome (MDS) Drugs Market Size by Type 6.4 Europe Myelodysplastic Syndrome (MDS) Drugs Market Size by Application 7 China 7.1 China Myelodysplastic Syndrome (MDS) Drugs Market Size (2014-2019) 7.2 Myelodysplastic Syndrome (MDS) Drugs Key Players in China 7.3 China Myelodysplastic Syndrome (MDS) Drugs Market Size by Type 7.4 China Myelodysplastic Syndrome (MDS) Drugs Market Size by Application 8 Japan 8.1 Japan Myelodysplastic Syndrome (MDS) Drugs Market Size (2014-2019) 8.2 Myelodysplastic Syndrome (MDS) Drugs Key Players in Japan 8.3 Japan Myelodysplastic Syndrome (MDS) Drugs Market Size by Type 8.4 Japan Myelodysplastic Syndrome (MDS) Drugs Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Myelodysplastic Syndrome (MDS) Drugs Market Size (2014-2019) 9.2 Myelodysplastic Syndrome (MDS) Drugs Key Players in Southeast Asia 9.3 Southeast Asia Myelodysplastic Syndrome (MDS) Drugs Market Size by Type 9.4 Southeast Asia Myelodysplastic Syndrome (MDS) Drugs Market Size by Application 10 India 10.1 India Myelodysplastic Syndrome (MDS) Drugs Market Size (2014-2019) 10.2 Myelodysplastic Syndrome (MDS) Drugs Key Players in India 10.3 India Myelodysplastic Syndrome (MDS) Drugs Market Size by Type 10.4 India Myelodysplastic Syndrome (MDS) Drugs Market Size by Application 11 Central & South America 11.1 Central & South America Myelodysplastic Syndrome (MDS) Drugs Market Size (2014-2019) 11.2 Myelodysplastic Syndrome (MDS) Drugs Key Players in Central & South America 11.3 Central & South America Myelodysplastic Syndrome (MDS) Drugs Market Size by Type 11.4 Central & South America Myelodysplastic Syndrome (MDS) Drugs Market Size by Application 12 International Players Profiles 12.1 Celgene 12.1.1 Celgene Company Details 12.1.2 Company Description and Business Overview 12.1.3 Myelodysplastic Syndrome (MDS) Drugs Introduction 12.1.4 Celgene Revenue in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019) 12.1.5 Celgene Recent Development 12.2 Amgen 12.2.1 Amgen Company Details 12.2.2 Company Description and Business Overview 12.2.3 Myelodysplastic Syndrome (MDS) Drugs Introduction 12.2.4 Amgen Revenue in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019) 12.2.5 Amgen Recent Development 12.3 Otsuka 12.3.1 Otsuka Company Details 12.3.2 Company Description and Business Overview 12.3.3 Myelodysplastic Syndrome (MDS) Drugs Introduction 12.3.4 Otsuka Revenue in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019) 12.3.5 Otsuka Recent Development 12.4 Takeda 12.4.1 Takeda Company Details 12.4.2 Company Description and Business Overview 12.4.3 Myelodysplastic Syndrome (MDS) Drugs Introduction 12.4.4 Takeda Revenue in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019) 12.4.5 Takeda Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Myelodysplastic Syndrome (MDS) Drugs Key Market Segments Table Key Players Myelodysplastic Syndrome (MDS) Drugs Covered Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Size Market Share by Type 2014-2025 Figure Hypomethylating Agents Figures Table Key Players of Hypomethylating Agents Figure Immunomodulatory Drugs Figures Table Key Players of Immunomodulatory Drugs Figure Anti-anemics Figures Table Key Players of Anti-anemics Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size Growth by Application 2014-2025 (Million US$) Figure Original Case Studies Figure Generics Case Studies Figure Myelodysplastic Syndrome (MDS) Drugs Report Years Considered Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size 2014-2025 (Million US$) Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Size and Growth Rate 2014-2025 (Million US$) Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Regions 2014-2025 (Million US$) Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Regions 2014-2019 (Million US$) Table Global Myelodysplastic Syndrome (MDS) Drugs Market Share by Regions 2014-2019 Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Share by Regions 2014-2019 Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Share by Regions 2019 Table Market Top Trends Table Global Myelodysplastic Syndrome (MDS) Drugs Revenue by Manufacturers (2014-2019) (Million US$) Table Global Myelodysplastic Syndrome (MDS) Drugs Market Share by Manufacturers (2014-2019) Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Share by Manufacturers in 2018 Table Global Myelodysplastic Syndrome (MDS) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Myelodysplastic Syndrome (MDS) Drugs Product/Solution/Service Table Date of Enter into Myelodysplastic Syndrome (MDS) Drugs Market Table Mergers & Acquisitions, Expansion Plans Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Type (2014-2019) (Million US$) Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size Share by Type (2014-2019) Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Size Market Share by Type (2014-2019) Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Application (2014-2019) (Million US$) Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size Share by Application (2014-2019) Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Size Market Share by Application (2014-2019) Figure Global Myelodysplastic Syndrome (MDS) Drugs Revenue Market Share by Application in 2018 Figure United States Myelodysplastic Syndrome (MDS) Drugs Market Size 2014-2019 (Million US$) Table United States Key Players Myelodysplastic Syndrome (MDS) Drugs Revenue (2018-2019) (Million US$) Table United States Key Players Myelodysplastic Syndrome (MDS) Drugs Market Share (2018-2019) Table United States Myelodysplastic Syndrome (MDS) Drugs Market Size by Type (2014-2019) (Million US$) Table United States Myelodysplastic Syndrome (MDS) Drugs Market Share by Type (2014-2019) Table United States Myelodysplastic Syndrome (MDS) Drugs Market Size by Application (2014-2019) (Million US$) Table United States Myelodysplastic Syndrome (MDS) Drugs Market Share by Application (2014-2019) Figure Europe Myelodysplastic Syndrome (MDS) Drugs Market Size 2014-2019 (Million US$) Table Europe Key Players Myelodysplastic Syndrome (MDS) Drugs Revenue (2018-2019) (Million US$) Table Europe Key Players Myelodysplastic Syndrome (MDS) Drugs Market Share (2018-2019) Table Europe Myelodysplastic Syndrome (MDS) Drugs Market Size by Type (2014-2019) (Million US$) Table Europe Myelodysplastic Syndrome (MDS) Drugs Market Share by Type (2014-2019) Table Europe Myelodysplastic Syndrome (MDS) Drugs Market Size by Application (2014-2019) (Million US$) Table Europe Myelodysplastic Syndrome (MDS) Drugs Market Share by Application (2014-2019) Figure China Myelodysplastic Syndrome (MDS) Drugs Market Size 2014-2019 (Million US$) Table China Key Players Myelodysplastic Syndrome (MDS) Drugs Revenue (2018-2019) (Million US$) Table China Key Players Myelodysplastic Syndrome (MDS) Drugs Market Share (2018-2019) Table China Myelodysplastic Syndrome (MDS) Drugs Market Size by Type (2014-20189) (Million US$) Table China Myelodysplastic Syndrome (MDS) Drugs Market Share by Type (2014-2019) Table China Myelodysplastic Syndrome (MDS) Drugs Market Size by Application (2014-2019) (Million US$) Table China Myelodysplastic Syndrome (MDS) Drugs Market Share by Application (2014-2019) Figure Japan Myelodysplastic Syndrome (MDS) Drugs Market Size 2014-2019 (Million US$) Table Japan Key Players Myelodysplastic Syndrome (MDS) Drugs Revenue (2018-2019) (Million US$) Table Japan Key Players Myelodysplastic Syndrome (MDS) Drugs Market Share (2018-2019) Table Japan Myelodysplastic Syndrome (MDS) Drugs Market Size by Type (2014-2019) (Million US$) Table Japan Myelodysplastic Syndrome (MDS) Drugs Market Share by Type (2014-2019) Table Japan Myelodysplastic Syndrome (MDS) Drugs Market Size by Application (2014-2019) (Million US$) Table Japan Myelodysplastic Syndrome (MDS) Drugs Market Share by Application (2014-2019) Figure Southeast Asia Myelodysplastic Syndrome (MDS) Drugs Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Myelodysplastic Syndrome (MDS) Drugs Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Myelodysplastic Syndrome (MDS) Drugs Market Share (2018-2019) Table Southeast Asia Myelodysplastic Syndrome (MDS) Drugs Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Myelodysplastic Syndrome (MDS) Drugs Market Share by Type (2014-2019) Table Southeast Asia Myelodysplastic Syndrome (MDS) Drugs Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Myelodysplastic Syndrome (MDS) Drugs Market Share by Application (2014-2019) Figure India Myelodysplastic Syndrome (MDS) Drugs Market Size 2014-2019 (Million US$) Table India Key Players Myelodysplastic Syndrome (MDS) Drugs Revenue (2018-2019) (Million US$) Table India Key Players Myelodysplastic Syndrome (MDS) Drugs Market Share (2018-2019) Table India Myelodysplastic Syndrome (MDS) Drugs Market Size by Type (2014-2019) (Million US$) Table India Myelodysplastic Syndrome (MDS) Drugs Market Share by Type (2014-2019) Table India Myelodysplastic Syndrome (MDS) Drugs Market Size by Application (2014-2019) (Million US$) Table India Myelodysplastic Syndrome (MDS) Drugs Market Share by Application (2014-2019) Figure Central & South America Myelodysplastic Syndrome (MDS) Drugs Market Size 2014-2019 (Million US$) Table Central & South America Key Players Myelodysplastic Syndrome (MDS) Drugs Revenue (2018-2019) (Million US$) Table Central & South America Key Players Myelodysplastic Syndrome (MDS) Drugs Market Share (2018-2019) Table Central & South America Myelodysplastic Syndrome (MDS) Drugs Market Size by Type (2014-2019) (Million US$) Table Central & South America Myelodysplastic Syndrome (MDS) Drugs Market Share by Type (2014-2019) Table Central & South America Myelodysplastic Syndrome (MDS) Drugs Market Size by Application (2014-2019) (Million US$) Table Central & South America Myelodysplastic Syndrome (MDS) Drugs Market Share by Application (2014-2019) Table Celgene Company Details Table Celgene Revenue in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019) (Million US$) Figure Celgene Revenue Growth Rate in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019) Table Celgene Recent Development Table Amgen Company Details Table Amgen Revenue in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019)(Million US$) Figure Amgen Revenue Growth Rate in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019) Table Amgen Recent Development Table Otsuka Company Details Table Otsuka Revenue in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019)(Million US$) Figure Otsuka Revenue Growth Rate in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019) Table Otsuka Recent Development Table Takeda Company Details Table Takeda Revenue in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019)(Million US$) Figure Takeda Revenue Growth Rate in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019) Table Takeda Recent Development Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Regions (Million US$) 2019-2025 Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Size Share by Regions (2019-2025) Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Size Share by Regions in 2025 Figure United States Myelodysplastic Syndrome (MDS) Drugs Market Size Forecast (2019-2025)(Million USD) Figure Europe Myelodysplastic Syndrome (MDS) Drugs Market Size Forecast (2019-2025)(Million USD) Figure China Myelodysplastic Syndrome (MDS) Drugs Market Size Forecast (2019-2025)(Million USD) Figure Japan Myelodysplastic Syndrome (MDS) Drugs Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Myelodysplastic Syndrome (MDS) Drugs Market Size Forecast (2019-2025)(Million USD) Figure India Myelodysplastic Syndrome (MDS) Drugs Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Myelodysplastic Syndrome (MDS) Drugs Market Size Forecast (2019-2025)(Million USD) Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Product (2019-2025) (Million US$) Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Product (2019-2025) Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Product in 2025 Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Application (2019-2025) (Million US$) Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Application (2019-2025) Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Celgene Amgen Otsuka Takeda